Jared Holz, Mizuho, joins ‘Fast Money’ to talk opportunities in pharma investing following approval of Emergent Bio’s Mpox vaccine.
07:04
2 minutes ago
Trending
- Mark Cuban tried to invest in Musical.ly before it became TikTok
- The tennis stories of 2024, from doping bans and Grand Slam titles to a bee invasion
- An options strategy to generate income on this ‘Dog of the S&P 500’
- How 24-year-olds spend their 6-figure incomes in New York, California
- 10-year Treasury yield rises above 4.6% as investors digest jobless claims data
- Quantum computing stocks took off this year. What’s next for the trend in 2025
- Nippon Steel pushes deadline to close U.S. Steel deal as Biden decision looms
- A look back at U.S. airlines’ wild 2024, from door plugs to bankruptcy
Upside for Emergent Bio if they can get Mpox vaccine rollout right, says Mizuho’s Jared Holz
